TEK and neoplasm: Conversely, inhibiting Tie2 activity has demonstrated its ability to impede tumor angiogenesis and limit the growth of various cancer types, such as breast cancer, melanoma, and hepatocellular carcinoma, in numerous mouse models [56,57,58,59].